Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Abbvie Inc (ABBV)

107.985   -0.705 (-0.65%) 02-25 11:57
Open: 108.48 Pre. Close: 108.69
High: 109.22 Low: 107.76
Volume: 1,956,311 Market Cap: 190,689M
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 109.535 - 110.307 110.307 - 110.906
Low: 104.174 - 104.983 104.983 - 105.611
Close: 107.622 - 108.888 108.888 - 109.871

Technical analysis

as of: 2021-02-25 11:41:25 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 131.69     One year: 153.82
Support: Support1: 105.99    Support2: 101.81
Resistance: Resistance1: 112.75    Resistance2: 131.69
Pivot: 106.23
Moving Average: MA(5): 107.04     MA(20): 105.65
MA(100): 100.30     MA(250): 93.66
MACD: MACD(12,26): 0.18     Signal(9): -0.14
Stochastic oscillator: %K(14,3): 65.63     %D(3): 59.25
RSI: RSI(14): 55.48
52-week: High: 113.41  Low: 62.55  Change(%): 26.2
Average Vol(K): 3-Month: 733884  10-Days: 600568

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ABBV has closed below upper band by 21.3%. Bollinger Bands are 33.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Tue, 23 Feb 2021
AbbVie Inc. stock falls Tuesday, underperforms market - MarketWatch

Mon, 22 Feb 2021
AbbVie Inc. stock outperforms market on strong trading day - MarketWatch

Sun, 21 Feb 2021
Is It Too Late to Buy AbbVie Stock? - Motley Fool

Fri, 19 Feb 2021
AbbVie Inc. stock falls Friday, underperforms market - MarketWatch

Thu, 18 Feb 2021
AbbVie Declares Quarterly Dividend - Yahoo Finance

Thu, 11 Feb 2021
AbbVie Inc. stock falls Thursday, underperforms market - MarketWatch

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Outperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General
Shares Out. (M) 1,770
Shares Float (M) 1,740
% Held by Insiders 0.10
% Held by Institutions 70.00
Shares Short (K) 12,590
Shares Short P. Month (K) 13,850

Stock Financials

EPS 4.570
EPS Est This Year 5.530
EPS Est Next Year 6.560
Book Value (p.s.) 8.650
Profit Margin 18.16
Operating Margin 33.11
Return on Assets (ttm) 8.1
Return on Equity (ttm) 209.1
Qtrly Rev. Growth 52.2
Gross Profit (p.s.) 14.593
Sales Per Share 22.966
EBITDA (p.s.) 10.379
Qtrly Earnings Growth 22.50
Operating Cash Flow (M) 16,010
Levered Free Cash Flow (M) 13,840

Stock Valuations

PE Ratio 23.67
PEG Ratio
Price to Book value 12.51
Price to Sales 4.71
Price to Cash Flow 11.96

Stock Dividends

Dividend 4.720
Forward Dividend 5.200
Dividend Yield 0.04
Dividend Pay Date 2021-02-15
Ex-Dividend Date 2021-01-13
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.